Page last updated: 2024-08-23

etoposide and veliparib

etoposide has been researched along with veliparib in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Beumer, J; Chen, A; Chen, Z; Christner, SM; Deng, X; Doho, GH; Khuri, FR; Kim, S; Kowalski, J; Li, C; Owonikoko, TK; Ramalingam, SS; Rossi, MR; Sica, GL; Strychor, S; Sun, SY; Switchenko, JM; Yue, P; Zhang, G1
Aggarwal, C; Belani, CP; Dahlberg, SE; Dowell, J; Gerber, DE; Hann, CL; Khan, SA; Moss, RA; Owonikoko, TK; Ramalingam, SS1
de Stanchina, E; Desmeules, P; Gardner, EE; Lok, BH; Ni, A; Poirier, JT; Powell, SN; Rekhtman, N; Riaz, N; Rudin, CM; Schneeberger, VE; Teicher, BA1
Baker, K; Blackhall, F; Dive, C; Forster, M; Foy, V; Frese, KK; Gomes, F; Lallo, A; Schenk, MW1
Atrafi, F; Byers, LA; Calles, A; Camidge, DR; Chae, YK; Gabrail, NY; Garralda, E; Groen, HJM; He, L; Hoening, E; Hu, B; Komarnitsky, P; Lolkema, MP; Nuthalapati, S; Sangha, RS; Tian, T; Viteri, S1
Aggarwal, C; Cella, D; Dahlberg, SE; Feliciano, JL; Lash, BW; Leach, JW; Leal, TA; Mohindra, NA; Owonikoko, TK; Ramalingam, SS; Srkalovic, G; Steffen McLouth, LE; Wade, JL; Wagner, LI; Zhao, F1
Bach, BA; Bentsion, D; Byers, LA; de Groot, P; Dunbar, M; Ellis, PM; Fujimoto, J; Gans, S; Gay, CM; Glasgow, J; Groen, HJM; He, L; Kang, K; Owonikoko, TK; Penkov, K; Sehgal, V; Sibille, A; Son, C1

Reviews

1 review(s) available for etoposide and veliparib

ArticleYear
Targeting DNA damage in SCLC.
    Lung cancer (Amsterdam, Netherlands), 2017, Volume: 114

    Topics: Aurora Kinases; Azepines; Benzimidazoles; Carbolines; Cell Cycle Checkpoints; Cell Proliferation; Cytotoxins; DNA Damage; DNA Repair; Etoposide; Genomic Instability; Heterocyclic Compounds, 4 or More Rings; Humans; Lung Neoplasms; Molecular Targeted Therapy; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Protein Kinase Inhibitors; Pyrimidines; Rad51 Recombinase; Small Cell Lung Carcinoma

2017

Trials

4 trial(s) available for etoposide and veliparib

ArticleYear
A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511).
    Lung cancer (Amsterdam, Netherlands), 2015, Volume: 89, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Etoposide; Fatigue; Female; Heart Failure; Humans; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Thrombocytopenia

2015
A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 01-15, Volume: 25, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carboplatin; Etoposide; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neoplasms; Small Cell Lung Carcinoma; Treatment Outcome

2019
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial.
    Cancer medicine, 2020, Volume: 9, Issue:20

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carboplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Medication Adherence; Middle Aged; Patient Reported Outcome Measures; Peripheral Nervous System Diseases; Small Cell Lung Carcinoma

2020
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2021, 07-15, Volume: 27, Issue:14

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carboplatin; Double-Blind Method; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Treatment Outcome

2021

Other Studies

2 other study(ies) available for etoposide and veliparib

ArticleYear
Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer.
    Cancer medicine, 2014, Volume: 3, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carboplatin; Cell Line, Tumor; Chemoradiotherapy; Cisplatin; Drug Synergism; Etoposide; Humans; In Vitro Techniques; Lung Neoplasms; Mice; Mice, Nude; Poly(ADP-ribose) Polymerase Inhibitors; Random Allocation; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays

2014
PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Jan-15, Volume: 23, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Line, Tumor; Cisplatin; Dacarbazine; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Genomics; Humans; Indoles; Mice; Nuclear Proteins; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Small Cell Lung Carcinoma; Temozolomide; Xenograft Model Antitumor Assays

2017